| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 58.092 | 58.601 | 134.605 | 94.089 | 83.326 | 88.549 | 79.007 | 71.390 | 87.180 | 97.654 |
| Total Income - EUR | 58.092 | 58.601 | 134.605 | 101.643 | 83.326 | 88.549 | 79.007 | 71.390 | 87.180 | 97.654 |
| Total Expenses - EUR | 56.838 | 59.957 | 125.913 | 95.463 | 73.288 | 81.577 | 84.040 | 66.581 | 91.161 | 98.108 |
| Gross Profit/Loss - EUR | 1.254 | -1.356 | 8.692 | 6.180 | 10.038 | 6.972 | -5.033 | 4.809 | -3.982 | -454 |
| Net Profit/Loss - EUR | 1.053 | -1.356 | 7.371 | 5.166 | 9.035 | 6.086 | -5.959 | 4.095 | -4.854 | -1.430 |
| Employees | 4 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Nicofarm Vet Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 7.696 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 22.399 | 25.215 | 25.339 | 29.621 | 23.748 | 28.240 | 20.823 | 24.804 | 8.955 | 5.091 |
| Inventories | 20.607 | 23.627 | 13.456 | 2.472 | 8.815 | 8.342 | -571 | 5.884 | 5.397 | 4.928 |
| Receivables | 546 | 312 | -520 | 1.466 | 173 | 2.230 | 1.949 | 55 | 54 | 54 |
| Cash | 1.247 | 1.276 | 12.402 | 25.683 | 14.760 | 17.668 | 19.445 | 18.866 | 3.504 | 109 |
| Shareholders Funds | 8.695 | 7.250 | 14.499 | 19.399 | 9.077 | 14.991 | 8.700 | 12.822 | -4.813 | -6.217 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 13.703 | 17.965 | 18.535 | 10.222 | 14.670 | 13.248 | 12.123 | 11.982 | 13.769 | 11.307 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Nicofarm Vet Srl